Video brief · 2026-09-09

What Does BPC-157 Actually Do? What the Research Shows

60-second brief · educational content · not medical advice

BPC-157 is one of the most talked-about peptides online, so it is worth asking plainly what the published research shows. It is a synthetic chain of fifteen amino acids, based on a fragment of a protein found in human gastric juice. The synthetic peptide is not something the body makes, it is not approved as a medicine in the United States, the EU or the UK, and the World Anti-Doping Agency prohibits it at all times.

Almost everything published about BPC-157 is animal work, mostly in rats, and much of it from a single research group in Croatia. In those studies it has been reported to speed healing of tendon, muscle, bone, gut and nerve injuries, often with large effects. That literature is substantial. It is also almost entirely preclinical, and effects that large in rodents very often shrink or disappear in people.

In humans, one genuine trial has ever been registered. ClinicalTrials.gov record NCT02637284 was a Phase One safety and pharmacokinetics study in forty-two healthy volunteers that began in 2015. A Phase One trial looks at safety and how a substance moves through the body, not whether it works. Its status is still Unknown and it has never posted results. A 2025 record tested a commercial peptide gummy in forty people and has posted nothing. A third record that looked like a hamstring trial turned out to be a template entry sharing a sponsor and site with a record that calls itself fictional.

So no human trial has ever tested BPC-157 for tendon healing, the use it is most often marketed for, and no human study has run beyond weeks. Whether oral forms survive digestion, and whether its blood-vessel-growth activity in animals matters for tumours, are open questions. Anyone weighing it for their own health should talk to a physician, because the human evidence does not yet exist. Sources are listed below.

Sources

ClinicalTrials.gov NCT02637284, Phase 1 safety and pharmacokinetics of PCO-02 (BPC-157), n=42, status Unknown, no results posted
ClinicalTrials.gov, 2015
ClinicalTrials.gov NCT07752381, peptide gummies and markers of inflammation and recovery, n=40, no results posted
ClinicalTrials.gov, 2025
Peptide Proof, BPC-157 peptide profile and registry audit (correction of 31 August 2026 on template records)
thepeptideproof.com, 2026

Peptide Proof reports what studies found. We do not give medical advice, dosing guidance, or treatment recommendations.